CIK 0001645113
- Large accelerated filer
NovoCure Ltd
Sign in to watch- Ticker
- NVCR
- Exchange
- Nasdaq
- Industry
- Surgical & Medical Instruments & Apparatus
- FY end
- Dec 31
- Entity type
- Operating
- Phone
- +44 1534756700
- Business address
- NO. 4 THE FORUM, GRENVILLE STREET, ST. HELIER, Jersey
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $142,786
- in 3 filings
Net −$142,786. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2022-07-05 | Danziger Asaf Chief Executive Officer | Grant or award | +276 | $59.08 | $16K | 13,583 |
| 2022-07-05 | Benaim Ely Chief Medical Officer | Grant or award | +222 | $59.08 | $13K | 35,068 |
| 2022-07-05 | Leonard Frank X Chief Development Officer | Grant or award | +312 | $59.08 | $18K | 102,607 |
| 2022-07-05 | Shah Pritesh Chief Commercial Officer | Grant or award | +312 | $59.08 | $18K | 83,499 |
| 2022-07-05 | Burke William Patrick Chief Human Resources Officer | Grant or award | +213 | $59.08 | $13K | 56,204 |
| 2022-06-10 | HILLEMAN JERYL L Director | Sale | −407 | $69.61 | $28K | 2,537 |
| 2022-06-08 | Madden Martin J. Director | Grant or award · Options to Buy Ordinary Shares | +8,700 | 8,700 | ||
| 2022-06-08 | Hung David Director | Grant or award | +2,427 | 9,141 | ||
| 2022-06-08 | Hung David Director | Grant or award · Options to Buy Ordinary Shares | +4,350 | 4,350 | ||
| 2022-06-08 | Scannell Timothy J Director | Grant or award · Options to Buy Ordinary Shares | +8,700 | 8,700 | ||
| 2022-06-08 | VERNON W ANTHONY Director | Grant or award · Options to Buy Ordinary Shares | +8,700 | 8,700 | ||
| 2022-06-08 | LEUNG GABRIEL Director | Grant or award | +2,427 | 75,286 | ||
| 2022-06-08 | LEUNG GABRIEL Director | Grant or award · Options to Buy Ordinary Shares | +4,350 | 4,350 | ||
| 2022-06-08 | HILLEMAN JERYL L Director | Grant or award · Options to Buy Ordinary Shares | +8,700 | 8,700 | ||
| 2022-05-11 | Benaim Ely Chief Medical Officer | Sale | −2,135 | $61.25 | $131K | 34,846 |
| 2022-05-10 | Benaim Ely Chief Medical Officer | Sale | −2,070 | $65.16 | $135K | 36,981 |
| 2022-05-05 | GROENHUYSEN WILHELMUS CM Chief Operating Officer | Gift · Options to Buy Ordinary Shares | −1,324 | 0 | ||
| 2022-05-05 | GROENHUYSEN WILHELMUS CM Chief Operating Officer | Gift · Options to Buy Ordinary Shares | +1,324 | 147,048 | ||
| 2022-03-09 | Shah Pritesh Chief Commercial Officer | Sale | −3,669 | $71.19 | $261K | 83,187 |
| 2022-03-08 | Shah Pritesh Chief Commercial Officer | Sale | −2,481 | $70.10 | $174K | 81,908 |
Page 21 of 32 · 638 trades